PIK3CA mutation and amplification in human lung cancer-Reference-Cited by-同舟云学术

PIK3CA mutation and amplification in human lung cancer

Published:2007-10 Issue:10 Volume:57 Page:664-671
ISSN:1320-5463
Container-title:Pathology International
language:en
Short-container-title:Pathol Int

Author:

Okudela Koji,Suzuki Masaya,Kageyama Shinji,Bunai Tomoyasu,Nagura Kiyoko,Igarashi Hisaki,Takamochi Kazuya,Suzuki Kazuya,Yamada Takeshi,Niwa Hiroshi,Ohashi Riuko,Ogawa Hiroshi,Mori Hiroki,Kitamura Hitoshi,Kaneko Takeshi,Tsuneyoshi Toshihiro,Sugimura Haruhiko

Publisher

Wiley

Subject

General Medicine,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1827.2007.02155.x/fullpdf

Reference28 articles.

1. Phosphoinositide 3-kinase: From viral oncoprotein to drug target

2. Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions

3. A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer

4. K-ras Gene Mutation Enhances Motility of Immortalized Airway Cells and Lung Adenocarcinoma Cells via Akt Activation

5. PI3K–AKT pathway mediates growth and survival signals during development of fetal mouse lung

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example;Molecular Biomedicine;2024-04-15

2. Prevalence and Associations of Co-occurrence of NFE2L2 Mutations and Chromosome 3q26 Amplification in Lung Cancer;Global Medical Genetics;2024-04-15

3. Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions;Frontiers in Oncology;2023-09-25

4. Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds;Cancers;2023-08-05

5. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer;Seminars in Cancer Biology;2021-06